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CD4+CD25−Foxp3+ T cells play 
a role in tuberculous hydrothorax rather 
than malignant hydrothorax
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Abstract 
Background: Foxp3+ T cells regulate inflammation and tumorigenesis. However, little is known about the role of dif‑
ferent subsets of Foxp3+ T cells in malignant or tuberculous hydrothorax.
Methods: The numbers of CD4+CD25+Foxp3+, CD4+CD25−Foxp3+ T cells and the levels of some inflammatory 
cytokines in patients with tuberculous hydrothorax, malignant hydrothorax, and healthy controls (HCs) were exam‑
ined by flow cytometry and ELISA. The potential association between the numbers of different subsets of Foxp3 + T 
cells and the values of clinical measures were analyzed.
Results: The numbers of peripheral blood CD4+CD25+Foxp3+ T cells were greater in malignant hydrothorax 
patients than in HCs, but fewer than those of hydrothorax in patients. The percentages of circulating IL‑10+ or LAP+ 
CD4+CD25+Foxp3+ T cells were higher than in the hydrothorax in patients with malignant hydrothorax. The num‑
bers of circulating CD4+CD25−Foxp3+ T cells were significantly fewer in patients with tuberculous hydrothorax 
than in HCs, and both the numbers of circulating CD4+CD25+Foxp3+ and CD4+CD25−Foxp3+ T cells were sig‑
nificantly fewer than in the hydrothorax in patients. Significantly higher percentages of circulating IL‑10+ or LAP+ 
CD4+CD25+Foxp3+ and CD4+CD25−Foxp3+ T cells were detected in tuberculous hydrothorax patients. The numbers 
of CD4+CD25+Foxp3+ and CD4+CD25−Foxp3+ T cells were associated with hydrothorax adenosine deaminase (ADA) 
levels in tuberculous hydrothorax patients, while CD4+CD25+Foxp3+ T cells were associated with carcino‑embryonic 
antigen (CEA) in malignant hydrothorax patients. The concentrations of serum IL‑6 and TGF‑β in the patients were sig‑
nificantly higher than that in the HCs, but lower than that in the corresponding hydrothorax. A similar pattern of IL‑10 
was observed in different groups, except that there was no significant difference in the levels of serum IL‑10 between 
the tuberculous hydrothorax patients and HCs.
Conclusions: CD4+CD25−Foxp3+ T cells, which have lower inhibitory function than CD4+CD25+Foxp3+ T cells, may 
play a role in tuberculous hydrothorax.
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Background
Hydrothorax is a medical condition, which results from 
the disorder of pleural absorption due to a systemic or 
local disease. Lung cancer and tuberculosis infection are 
common factors for the formation of hydrothorax. Pre-
vious studies have suggested that immune escape par-
ticipates in the pathogenesis of malignant hydrothorax 
or tuberculous hydrothorax [1–3]. It is known that regu-
latory T cells (Treg) are crucial for peripheral tolerance, 
and they actively and predominately inhibit both the acti-
vation and effector function of autoreactive T cells [4, 5]. 
However, little is known about the potential role of Tregs 
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in the pathogenesis of malignant hydrothorax and tuber-
culous hydrothorax.
Treg are characterized by CD4+CD25+ [6] and 
express the forkhead family transcription factor 
(Foxp3), which is necessary for the development and 
function of Tregs [7–9]. Foxp3 has been described as 
a highly specific intracellular marker for Tregs. The 
CD4+CD25+FoxP3+ Tregs have potent suppressive 
activity to prevent pathogenic damage under inflam-
matory conditions, and they also have the tendency 
to keep tumors from host immunologic surveillance 
[10–12]. Therefore, CD4+CD25+FoxP3+ Tregs can 
promote immune escape of tumor cells and Myco-
bacterium tuberculosis (M.tb). Indeed, high percent-
ages of CD4+CD25+FoxP3+ Tregs have been found in 
the hydrothorax of patients with tuberculous hydro-
thorax and malignant hydrothorax [13, 14]. How-
ever, a recent study reveals that CD4+CD25−FoxP3+ 
Tregs develop in the periphery and are derived from 
CD4+CD25− T cells, dependent on environmental anti-
gens presented by dendritic cells (DCs) [15]. Hence, 
CD4+CD25+FoxP3+ and CD4+CD25−Foxp3 Tregs are 
activated by different types of antigens and develop in 
varying environments [16]. However, the function of 
CD4+CD25−Foxp3+ Tregs is still unclear. One study 
indicates that CD4+CD25−FoxP3+ Tregs act similar 
to that of conventional Tregs to a certain extent [17], 
but another study reveals that CD4+CD25−Foxp3+ 
Tregs are different from CD4+CD25+ Tregs both phe-
notypically and functionally [18]. IL-6 can convert 
CD4+CD25+FoxP3+ but not CD4+CD25−FoxP3+ Tregs 
to Th17 cells [19], and CD4+CD25−FoxP3+ Tregs may 
retain suppressive function in an inflammatory environ-
ment [20]. The difference in their mechanisms of gen-
eration and in the sensitivity to IL-6 on their functional 
properties suggests that they may have different roles in 
the adaptive immune response [11]. However, there are 
few researches that distinguish the roles of FoxP3+ Tregs 
between malignant and tuberculous hydrothorax, and 
there is no study that distinguishes CD4+CD25−FoxP3+ 
from CD4+CD25+FoxP3+ Tregs during the process 
of malignant and tuberculous hydrothorax. Given 
that Tregs express IL-10 and latency associated pep-
tide (LAP), it is unclear how the frequency of IL-10+ 
or LAP+ CD4+CD25+FoxP3+ or CD4+CD25−FoxP3+ 
Tregs changes in patients with malignant and tubercu-
lous hydrothorax.
Tregs can negatively regulate NK cell function, B cell 
activation, and humoral responses [11, 18]. Previous 
studies have shown increased numbers of CD4+ T cells 
in both malignant and tuberculous hydrothorax patients 
[21–23] and decreased numbers of B cells in tuberculous 
hydrothorax patients [24, 25]. NK cells have potent anti-
tumor and anti-tuberculosis activity in malignant and 
tuberculous hydrothorax [26, 27]. However, whether the 
frequency of T, B, and NK cells are similar or different 
between malignant and tuberculous hydrothorax has not 
been clarified.
In the present study, we tested the hypothesis that 
CD4+CD25+Foxp3+ and CD4+CD25−Foxp3+ Tregs may 
play different roles in the pathogenesis of malignant and 
tuberculous hydrothorax, and we found that both the 
numbers and secretary function of CD4+CD25+Foxp3+ 
and CD4+CD25−Foxp3+ T cells changed in the devel-
opment of tuberculous hydrothorax, while only 




Forty-nine patients with hydrothorax (25 tuberculosis and 
24 pulmonary tumors) were recruited sequentially from 
the inpatient service of the First Hospital of Jilin Univer-
sity from March 2012 to May 2013. Another 23 age-, gen-
der-, and ethnicity-matched healthy volunteers from the 
Physical Examination Center were recruited as healthy 
controls (HCs), and they had no historical or current 
chronic disease and smoking. One patient with tubercu-
lous hydrothorax was diagnosed by the detection of M.tb 
on a hydrothorax smear, and other 24 patients were diag-
nosed with positive pleural biopsy specimen with granu-
lomatous pleurisy in the absence of evidence of other 
granulomatous diseases. Patients with malignant hydro-
thorax were diagnosed by detection of malignant cells 
in the hydrothorax and/or biopsied pleural specimens. 
Patients were excluded if she/he received anti-cancer, 
anti-tuberculosis therapy, corticosteroids, or immunosup-
pressants for any reason or had renal, hepatic, endocrine 
diseases, or were pregnant. Written informed consent was 
obtained from each individual subject, and the experi-
mental protocol was approved by the Ethical Committee 
of the First Hospital of Jilin University.
Clinical measurements
The concentrations of serum and hydrothorax carci-
noembryonic antigen (CEA) were determined by the 
chemiluminescence immunoassay using a specific kit, 
according to the manufacturers’ instruction (Beckman 
Coulter, Fullerton, USA). The levels of lactate dehydroge-
nase (LDH) and adenosine deaminase (ADA) in individ-
ual samples were determined by the enzyme colorimetry 
using specific kits (Huachenbio, Shanghai, China) and 
(Aosibangbio, Yantai, China), respectively, according to 
the manufacturer’s protocols.
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Cell isolation and flow cytometry
Venous blood (10 mL) and hydrothorax (15 mL) samples 
were collected and centrifuged at 1,500 rpm for 10 min. 
The pelleted cells were subjected to density-gradient 
centrifugation to prepare peripheral blood mononuclear 
cells and hydrothorax mononuclear cells. The cells (106 
cells/tube) were stained in duplicate with fluorescein 
isothiocyanate (FITC)-anti-CD4 (BD PharMingen, San 
Diego, USA) and APC-anti-CD25 (BD PharMingen) at 
room temperature (RT) for 30 min, fixed with 1× Human 
FoxP3 Buffer A (10 min/RT), and permeabilized with 1× 
working solution of Human FoxP3 Buffer C for 30 min at 
RT. After being washed with PBS, the cells were stained 
with phycoerythrin (PE)-anti-FoxP3 (BD PharMin-
gen) for 30  min and characterized by flow cytometry 
analysis using a FACS Calibur (BD Biosciences) and 
FlowJo software (v5.7.2) (TreeStar, Ashland, USA). The 
cells were gated initially on living lymphocytes, accord-
ing to the basis of forward and side angle light scat-
tering characteristics. Subsequently, the cells were 
gated on CD4+ T cells to determine the frequency of 
CD4+CD25+Foxp3+ and CD4+CD25−Foxp3+ Tregs in 
total CD4+ T cells. The numbers of CD4+CD25+Foxp3+ 
and CD4+CD25−Foxp3+ Tregs in peripheral blood were 
calculated by the formula (cell numbers =  lymphocytes 
number (gain from routine blood test)  ×  CD4+lymphocyte cells
%  ×  CD25+or - FoxP3+
CD4+
cells%), and in hydrothorax by the 
formula (cell numbers = hydrothorax leukocyte numbers 
(gain from routine hydrothorax test) × mononuclear cells 




To determine the other types of lymphocytes, the 
prepared peripheral blood mononuclear cells and 
hydrothorax mononuclear cells were stained with 
FITC-anti-CD4, PE-anti-CD8, peridinin chlorophyll-
a protein (PerCP)-anti-CD3 (BD Tritest, San Jose, CA, 
USA), or FITC-anti-CD5, PE-anti-CD19 (BD Simul-
test, San Jose, CA, USA), or FITC-anti-CD3, PE-anti-
CD16CD56 (BD Simultest), respectively at RT for 
30  min. After being washed, the cells were character-
ized by flow cytometry analysis. The cells were gated 
initially on living lymphocytes. The numbers of CD3+, 
CD3+CD4+, CD3+CD8+ T cells, CD5+CD19+ B cells, 
and CD3−CD16CD56+ NK cells in peripheral blood were 
calculated according to the formula (cell numbers = lym-
phocyte absolute numbers (gain from routine blood test)  
×  CD3+or CD3+CD4+or CD3+CD8+ or CD5+CD19+ or CD3−CD16CD56+
lymphocyte
cells
%), and in hydrothorax by the formula (cell num-
bers  =  hydrothorax leukocyte number (gain 
from routine hydrothorax test)  ×  mononu-
clear cells % (gain from routine hydrothorax test)   




The detection of IL‑10+ or LAP+ CD4+Foxp3+ Tregs
The peripheral blood mononuclear cells and hydrotho-
rax mononuclear cells (106 cells/well) were stimulated 
in duplicate with 50  ng/mL of phorbol myristate acetate 
(PMA) and 1.0  μg/mL of ionomycin (Sigma-Aldrich, St. 
Louis, USA) in complete RPMI 1640 medium for 2  h at 
37°C in 5% CO2 and exposed to Brefeldin A (GolgiPlug; BD 
Biosciences) for 4  h. The cells cultured in medium alone 
without stimulation served as negative controls. After 
being washed, the cells were stained in duplicate with 
PerCP-anti-CD4 and APC-anti-CD25, fixed, permeabi-
lized, followed by intracellular staining with PE-anti-FoxP3 
and Alexa Fluor 488-anti-IL-10 (eBioscience, San Diego, 
USA) or control IgG1 (eBioscience, San Diego, USA) for 
30 min, or stained with PerCP-anti-CD4, APC-anti-CD25, 
Alexa Fluor 488-anti-LAP (eBioscience) or control IgG1 
(eBioscience, San Diego, USA), fixed, permeabilized, and 
followed by PE-anti-FoxP3 for 30  min. Finally, the cells 
were characterized by flow cytometry analysis. The cells 
were gated initially on living lymphocytes, and then on 
CD4+ T cells. Subsequently, the CD4+CD25+Foxp3+ and 
CD4+CD25−Foxp3+ Tregs were analyzed. The numbers 
of IL-10+ or LAP+ CD4+Foxp3+ Tregs were calculated 
by the formula (cell numbers  =  CD4+CD25+or−Foxp3+ 
numbers  ×  IL - 10+or LAP+
CD4+CD25+or - Foxp3+
cells%). At least 20,000 
events were analyzed for each sample in all flow cytometry 
analysis.
Measurement of cytokines
The concentrations of IL-6 and IL-10 were determined by 
cytometric bead array (CBA) using a commercial kit (BD 
Biosciences, San Joes, USA), and were quantified using 
the Cell Quest Pro and CBA software (Becton–Dickin-
son) on a FACS Calibur cytometry. The concentrations of 
transforming growth factor-β (TGF-β) in individual sub-
jects were determined by enzyme linked immunosorbent 
assay (ELISA) using a human TGF-β ELISA kit (R&D Sys-
tems, Minneapolis, USA) and were calculated, according 
to the standard curve established using the recombinant 
TGF-β provided. The limitation of detection for IL-6, 
IL-10 or TGF-β was 2.5, 3.3, or 15.4 pg/mL, respectively.
Statistical analyses
Data are expressed as the median and range unless speci-
fied. The difference among the three groups was ana-
lyzed by ANOVA and post hoc Bonferroni analysis, and 
between two groups was analyzed by the Wilcoxon rank 
sum test using SPSS 16.0 software. A two-sided P value 
<0.05 was considered statistically significant.
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Results
Demographic and clinical characteristics of patients
As shown in Table 1, there was no significant difference in 
the distribution of age, gender, and the numbers of white 
blood count (WBC) among three groups, also in the num-
bers of lymphocytes between the peripheral blood from 
malignant hydrothorax patients and HCs, while the num-
bers of lymphocytes in the peripheral blood from tuber-
culous hydrothorax patients were significantly less than 
those in the malignant hydrothorax patients and HCs 
(p  <  0.05). In addition, the numbers of WBC, mononu-
clear cells and ADA in the malignant hydrothorax were 
significantly less than that in the tuberculous hydrothorax 
(p < 0.05), but the levels of CEA and LDH in the malig-
nant hydrothorax were higher than that in the tubercu-
lous hydrothorax (p < 0.05).
The numbers of T, B, and NK cells in tuberculous 
and malignant hydrothorax patients
Given that T, B, and NK cells play varying function in 
the pathogenesis of tuberculous and malignant hydro-
thorax, we first characterized the numbers of T, B and 
NK cells in peripheral blood and hydrothorax samples 
from tuberculous and malignant hydrothorax patients 
by flow cytometry analysis. The numbers of circulating 
CD3+, CD3+CD4+, and CD3+CD8+ T cells in the tuber-
culous hydrothorax patients were significantly less than 
that in the malignant hydrothorax patients (p < 0.05 for 
all) and HCs (p < 0.01 for all) (Fig.  1a–c). The numbers 
of circulating CD19+CD5+ B cells were similar between 
the tuberculous hydrothorax and malignant hydrotho-
rax patients and were significantly less than those in the 
HCs (p  <  0.001, Fig.  1e). Further analysis indicated that 
the numbers of CD3+ and CD3+CD4+ T cells in the 
tuberculous hydrothorax were significantly greater than 
that in blood (p < 0.001, Fig. 1a, b). However, there was 
no significant difference in the numbers of CD3+CD8+ 
T cells between blood and hydrothorax from tubercu-
lous hydrothorax patients (Fig. 1c). As a result, the ratios 
of hydrothorax CD4+ to CD8+ T cells were greater than 
that in the blood of the tuberculous hydrothorax patients 
(p < 0.001, Fig. 1d). In contrast, the numbers of hydrotho-
rax CD3−CD16/CD56+ NK cells were significantly less 
than that in blood in both the tuberculous and malignant 
hydrothorax patients (p < 0.001, Fig. 1f ).
Characterization of CD4+CD25+Foxp3+ 
and CD4+CD25−Foxp3+ Treg in patients with tuberculous 
hydrothorax and malignant hydrothorax
Next, we characterized the numbers of Tregs. The num-
bers of circulating CD4+CD25+Foxp3+ Tregs in the malig-
nant hydrothorax patients were significantly greater than 
those in the tuberculous hydrothorax patients and HCs 
(P < 0.001 for both, Fig. 2b), while the numbers of circu-
lating CD4+CD25−Foxp3+ Tregs in the tuberculous hydro-
thorax patients were significantly less than that in the HCs 
and malignant hydrothorax patients (P  <  0.05 for both, 
Fig.  2c). Further analysis indicated that the numbers of 
CD4+CD25+Foxp3+ Tregs were similar between the tuber-
culous and malignant hydrothorax and were significantly 
greater than those in the blood of both groups of patients 
(p  <  0.001 for both, Fig.  3a, b). In addition, the numbers 
of CD4+CD25−Foxp3+ Tregs in the tuberculous hydro-
thorax were significantly greater than those in the blood 
(p < 0.001) and malignant hydrothorax (p = 0.008, Fig. 3c).
The relationship between the numbers 
of CD4+CD25+Foxp3+ or CD4+CD25−Foxp3+ Tregs 
and clinical parameters
Because ADA and CEA are important biomarkers for 
tuberculous hydrothorax and malignant hydrotho-
rax, respectively. We further stratified patients and 
Table 1 The demographic and clinical characteristics of subjects
WBC white blood cell, CEA carcino-embryonic antigen, LDH lactate dehydrogenase, ADA adenosine deaminase, – not available.
* P < 0.05 vs. the HCs; # P < 0.05 vs. the tuberculous hydrothorax patients; the normal values for CEA, LDH, and ADA are 0–5 ng/mL, 135–226 U/L, and 0–25 U/L, 
respectively.
Characteristics Tuberculous hydrothorax  
(n = 25)
Malignant hydrothorax  
(n = 24)
HCs (n = 23)
Male/female 13/12 12/12 12/11
Age 45 (23–67) 55 (39–67) 48 (28–68)
Blood WBC (×109/L) 6.15 ± 1.94 6.59 ± 1.62 6.16 ± 1.33
Blood Lymphocyte (×109/L) 1.19 ± 0.38* 1.58 ± 0.33# 1.50 ± 0.35
Pleural fluid
 WBC (×106/mL) 2,340 (650–5,120) 1,730 (680–2,670)# _
 Mononuclear cells (×106/mL) 1,808 (520–4,096) 1,408 (544–2,286)# _
 CEA (ng/mL) 1.69 (0.46–5.8) 87.6 (1.43–951.5)# _
 LDH (U/L) 375 (192–1,249) 726 (208–1,180)# _
 ADA (U/L) 52.6 (3.5–113.2) 23.2 (3.7–48.7)# _
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analyzed the potential association between the numbers 
of Tregs and the levels of hydrothorax ADA or CEA in 
tuberculous hydrothorax or malignant hydrothorax 
patients. Considering that the level of ADA >45  U/L 
is usually recognized to be characteristic of tubercu-
lous hydrothorax, while CEA >20  U/L is characteristic 
of malignant hydrothorax, we used ADA =  45 U/L and 
CEA = 20 U/L as boundaries for stratification. The num-
bers of CD4+CD25+Foxp3+ and CD4+CD25−Foxp3+ 
Tregs in the tuberculous hydrothorax with ADA >45 U/L 
were significantly greater than those in the patients 
with ADA <45  U/L (P  =  0.049, P  =  0.011, Fig.  3d, e). 
Similarly, the numbers of CD4+CD25+Foxp3+, but not 
CD4+CD25−Foxp3+, Tregs in the malignant hydrothorax 
with CEA >20 U/L were significantly greater than those 
in the patients with CEA <20 U/L (P = 0.01, Fig. 3d).
The expression of IL‑10 or LAP on CD4+CD25+Foxp3+ 
and CD4+CD25−Foxp3+ T cells in malignant 
and tuberculous hydrothorax patients
IL-10 and LAP are expressed by CD4+CD25+Foxp3+ 
and CD4+CD25−Foxp3+ Tregs and are important for 
their function. Accordingly, we characterized IL-10+ 
or LAP+ Tregs by flow cytometry. We found the 
Fig. 1 The numbers of different subsets of lymphocyte in tuberculous and malignant hydrothorax patients. The peripheral blood and hydrothorax 
mononuclear cells were stained with specific antibodies respectively. The numbers of blood and hydrothorax CD3+, CD3+CD4+ T, CD3+CD8+ T, 
CD19+CD5+ B cells, and CD3−CD16/56+ NK cells were characterized by flow cytometry, and the ratios of CD4+ to CD8+ T cells were calculated in 
individual groups of subjects. Data shown are the mean values of individual subjects. a–c The numbers of CD3+, CD3+CD4+, and CD3+CD8+ T cells. 
d The ratios of CD4+ to CD8+ T cells. e, f The numbers of CD19+CD5+ B cells and CD3−CD16/56+ NK cells. The horizontal lines show the median 
values of individual groups. HCs healthy controls.
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frequency of IL-10+ or LAP+ CD4+CD25+Foxp3+ 
Treg was significantly higher than that of IL-10+ 
or LAP+ CD4+CD25−Foxp3+ Tregs in the HCs 
(p  <  0.05, Fig.  4b). The percentages of circulating IL-
10+CD4+CD25+Foxp3+ Tregs in the tuberculous hydro-
thorax patients were significantly higher than that of 
hydrothorax (p < 0.001) and that in the blood of malig-
nant hydrothorax patients (p = 0.02), which was also sig-
nificantly higher than that in the hydrothorax (p = 0.001) 
and in the HCs (p < 0.001, Fig. 4c). A similar pattern of 
LAP+CD4+CD25+Foxp3+ T cells was observed in the 
different groups of subjects (Fig.  4e). Furthermore, the 
percentages of circulating IL-10+CD4+CD25−Foxp3+ 
and LAP+CD4+CD25−Foxp3+ T cells in the tuberculous 
hydrothorax patients were significantly higher than that 
of hydrothorax and that in the HCs and malignant hydro-
thorax patients (Fig. 4d, f ).
The levels of different cytokines in tuberculous 
and malignant hydrothorax patients
The concentrations of serum IL-6 and TGF-β in both the 
tuberculous and malignant patients were significantly 
higher than that in the HCs, while lower than that in 
the hydrothorax from corresponding patients (p  <  0.05, 
Fig. 2 Flow cytometry analysis of the numbers of different phenotypes of peripheral blood Foxp3+ T cells. The peripheral blood and hydrothorax 
mononuclear cells were stained with anti‑CD4 and anti‑CD25, fixed and permeabilized, followed by staining with anti‑Foxp3. The cells were first 
gated on living lymphocytes and then on CD4+ cells, and the numbers of blood CD4+CD25+Foxp3+ and CD4+CD25−Foxp3+ T cells were charac‑
terized by flow cytometry analysis. Data shown are representative charts and expressed as the means of individual subjects. a Representative charts; 
b the numbers of CD4+CD25+Foxp3+ T cells; c the numbers of CD4+CD25−Foxp3+ T cells. The horizontal lines show the median values of individual 
groups. TB tuberculous patients, CA malignant patients.
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Fig. 5b, c), A similar pattern of IL-10 was observed in the 
different groups of samples, except that there was no sig-
nificant difference in the levels of serum IL-10 between 
the tuberculous hydrothorax patients and HCs (Fig. 5a). 
Furthermore, the levels of TGF-β in the malignant hydro-
thorax were significantly higher than that in the tubercu-
lous hydrothorax (p < 0.05).
Discussion
Tuberculous and malignant hydrothorax repre-
sent benign and malignant types of pleural effusion, 
respectively. Previous studies have indicated that Foxp3+ 
Tregs regulate immune responses in the development of 
tuberculosis and the growth of malignant tumors [28, 29]. 
In the present study, we found the numbers of peripheral 
blood CD4+CD25+Foxp3+ T cells were greater in malig-
nant hydrothorax patients than HCs, while less than the 
malignant hydrothorax. In addition, we found increased 
levels of IL-10 and TGF-β, which can negatively regu-
late effector T cells [30]. Tregs can accumulate in the 
early stage of tumorigenesis [31] and play a suppressive 
role through cell-to-cell contact mechanisms [32]. The 
Fig. 3 Flow cytometry analysis of the numbers of hydrothorax Foxp3+ T cells in tuberculous and malignant hydrothorax patients. The peripheral 
blood and hydrothorax mononuclear cells were stained with anti‑CD4 and anti‑CD25, fixed and permeabilized, followed by staining with anti‑
Foxp3. The cells were first gated on living lymphocytes and on CD4+ cells, and the numbers of blood and hydrothorax CD4+CD25+Foxp3+ and 
CD4+CD25−Foxp3+ T cells were characterized by flow cytometry analysis. Subsequently, the numbers of hydrothorax CD4+CD25+Foxp3+ and 
CD4+CD25−Foxp3+ T cells were stratified, according to the levels of hydrothorax ADA = 45 in tuberculous hydrothorax patients and CEA = 20 
in malignant hydrothorax patients. Data shown are representative charts and expressed as the means of individual subjects. a Representative 
charts; b the numbers of CD4+CD25+Foxp3+ T cells; c the numbers of CD4+CD25−Foxp3+ T cells. d stratification analysis of the numbers of 
CD4+CD25+Foxp3+ T cells. e Stratification analysis of the numbers of CD4+CD25−Foxp3+ T cells. The horizontal lines show the median values of 
individual groups.
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increased Tregs may promote cancer progression by 
interfering with immune surveillance because Tregs are 
an important inhibitory factor in the anti-tumor immu-
nity. Hence, therapeutic targeting of Tregs may be prom-
ising for the inhibition of tumor growth.
Tregs also participate in the immune responses 
against M.tb. Our data about the numbers of blood 
CD4+CD25+Foxp3+ T cells in tuberculous patients is 
different from the study by Semple and colleagues [33], 
which may be because the numbers of Tregs are reported 
by frequency in their research while absolute numbers in 
ours, and the decreased numbers of lymphocyte num-
bers in peripheral blood may contribute to this differ-
ence. Nowadays, CD4+CD25−FoxP3+ Tregs have been 
recognized as another subset of CD4+FoxP3+ Tregs. 
In the present study, we found that the numbers of cir-
culating CD4+CD25−FoxP3+ Tregs in the tuberculous 
hydrothorax patients were significantly less than those 
in the malignant patients and HCs, however, the num-
bers of CD4+CD25−FoxP3+ Tregs in the tuberculous 
Fig. 4 Flow cytometry analysis of the percentages of peripheral blood and hydrothorax IL‑10+ or LAP+ CD4+CD25+Foxp3+ and 
CD4+CD25−Foxp3+ T cells. The peripheral blood and hydrothorax mononuclear cells were stained with anti‑CD4 and anti‑CD25, fixed and per‑
meabilized, followed by staining with anti‑Foxp3 and anti‑IL‑10 (or control IgG1) or stained with anti‑CD4, anti‑CD25, and anti‑LAP (or control IgG1), 
fixed and permeabilized, followed by staining with anti‑Foxp3, respectively. The blood or hydrothorax mononuclear cells cultured in medium alone 
served as negative controls. The cells were first gated on CD4+ and then on CD4+CD25+Foxp3+ or CD4+CD25−Foxp3+ cells, followed by determin‑
ing the percentages of IL‑10+ or LAP+ CD4+CD25+Foxp3+ and CD4+CD25−Foxp3+ T cells. Data shown are representative charts and expressed as 
the means of individual subjects. a Representative charts. b The percentages of different phenotypes of Foxp3+ cells in the HCs. c–f The percent‑
ages of different phenotypes of Foxp3+ T cells in individual groups of subjects. The horizontal lines show the medians of individual groups.
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hydrothorax were significantly greater. The greater num-
bers of CD4+CD25−FoxP3+ Tregs in the tuberculous 
hydrothorax may stem from redistribution of this popu-
lation of T cells from peripheral blood to the inflam-
matory site during the process of M.tb infection [13]. 
Alternatively, CD4+CD25−Foxp3+ Tregs may constitute 
a peripheral reservoir of CD4+CD25+Foxp3+ Tregs [34].
Further stratification analysis indicated that the 
increased numbers of CD4+CD25+FoxP3+ and 
CD4+CD25−FoxP3+ Treg in the tuberculous hydrotho-
rax were associated with the levels of ADA in tuberculous 
patients. Given that the ADA can reflect T cell activation, 
the increased CD4+ FoxP3+ T cells may represent the 
extent of the inflammatory reaction. Moreover, we found 
significantly greater numbers of CD4+CD25+FoxP3+ T 
cells in the malignant hydrothorax patients with higher 
levels of hydrothorax CEA. The level of CEA is a valu-
able prognostic factor in patients with lung cancer, and 
the levels of serum CEA are correlated negatively with 
the survival periods of patients with lung cancer [7]. The 
association of greater numbers of malignant hydrotho-
rax CD4+CD25+FoxP3+ T cells with the higher levels of 
CEA suggests that CD4+CD25+FoxP3+ T cells may posi-
tively promote the growth of tumors.
IL-10 and TGF-β are the main cytokines which Tregs 
secreted, however, few researches have been designed 
to distinguish the function of CD4+CD25+FoxP3+ from 
CD4+CD25−FoxP3+ T cells. In the present study we 
found a significantly lower frequency of IL-10+ and LAP+ 
CD4+CD25−Foxp3+ Tregs compared to IL-10+ and 
LAP+ CD4+CD25+Foxp3+ Tregs in HCs. These data sug-
gest that some CD4+CD25−Foxp3+ Tregs may have no 
inhibitory function. Considering that early activated and 
uncommitted effector T cells, such as Th17, can express 
Foxp3, it is possible that some CD4+CD25−Foxp3+ Tregs 
may be early activated and uncommitted T cells [16, 35].
In addition, we found the percentages of circulat-
ing IL-10+ and LAP+ CD4+CD25+FoxP3+ Tregs in the 
tuberculous and malignant hydrothorax patients, espe-
cially in tuberculous patients, were higher than that 
in the HCs, and also higher than the corresponding 
hydrothorax. The lower frequency of IL-10+ and LAP+ 
CD4+CD25+FoxP3+Treg in the hydrothorax may be 
attributed to the inhibition of inflammatory cytokines, 
such as IL-6 [36]. Indeed, we detected significantly higher 
levels of IL-6 in both the tuberculous hydrothorax and 
malignant hydrothorax. In addition, the changes in the 
frequency of IL-10+ and LAP+ CD4+CD25−FoxP3+ 
Tregs were only found in tuberculous hydrothorax 
patients, which suggested that CD4+CD25−FoxP3+ 
Tregs might not be involved in the pathogenic process of 
tumorigenesis. Although there were significantly greater 
numbers of CD4+CD25+FoxP3+ Tregs in the periph-
eral blood of malignant hydrothorax patients than those 
in the tuberculous patients, the frequency of IL-10+ or 
LAP+ CD4+CD25+FoxP3+ Tregs was significantly lower. 
These data suggest the M.tb infection may enhance the 
immunity suppression of Tregs, which need to be further 
studied.
Moreover, we detected lower levels of TGF-β in 
the tuberculous hydrothorax than that in the malig-
nant hydrothorax, as well as fewer numbers of CD3+, 
CD3+CD4+, and CD3+CD8+ T cells in the peripheral 
blood of tuberculous hydrothorax than that in the malig-
nant hydrothorax patients. The different levels of such 
cytokines and cells may serve as biomarkers for dis-
tinguishing tuberculous hydrothorax from malignant 
hydrothorax.
Our findings suggest that CD4+CD25−Foxp3+ 
T cells may have lower inhibitory function than 
CD4+CD25+Foxp3+ T cells. CD4+CD25−Foxp3+ 
T cells may play a role in tuberculous rather than 
Fig. 5 The concentrations of peripheral blood and hydrothorax cytokines in different groups of subjects. The concentrations of peripheral blood 
and hydrothorax indicated cytokines in individual subjects were determined by ELISA and CBA. a–c Data shown are the means of cytokines in 
individual subjects, and the horizontal lines indicate the median values of individual groups.
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malignant  hydrothorax. CD4+CD25+Foxp3+ Tregs may 
participate in the inflammation process of M.tb infection 
and promote the growth of tumors. We are interested in 
further studying the dynamic changes of different subsets 
of Foxp3+ Tregs and the molecular mechanisms underly-
ing their actions.
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